 |
|
|
Resources for Patients & Families |
|
The ALS Research Pipeline |
|
While Riluzole is currently the only approved drug for ALS, other therapies are being investigated for their potential roles in ALS treatment. Read more >> |
|
Clinical Research Blog |
|
Read our blog dedicated to the advocacy of new clinical trials in motor neuron disease written by ALS Association/NEALS Clinical Trial Advocates. Join the conversation>> |
|
|
|
|
|
|
Resources for Researchers |
|
NEALS Samples |
|
Learn more about the tissue and fluid samples NEALS has available for research efforts in ALS and motor neuron diseases. Read More>> |
|
NEALS Databases |
|
NEALS has 6 de-indentified ALS trial databases available for mining. Collected since the birth of NEALS, these ALS trial databases are a great resource for ALS research. Get the data >> |
|
|
|
|
|
|
News & Events |
|
|
|
|
Brainstorm Initial Patient Results Support NurOwn Safety |
No significant side effects noted in initial Brainstorm participants.
Read the press release>> |
|
Positive Preliminary Phytopharm Results Shown by Cogane |
Cogane demonstrates efficacy in genetic preclinical model of ALS.
Read the main findings>>
Participants Needed for Biomarker Study
"Discovery and Validation of Biomarkers in ALS" is enrolling at 6 NEALS sites.
Read more >>
|
|
|
